China · Delayed Price · Currency is CNY G1 Therapeutics Statistics
Total Valuation
SHA:601633 has a market cap or net worth of CNY 174.08 billion. The enterprise value is 162.88 billion.
| Market Cap | 174.08B |
| Enterprise Value | 162.88B |
Important Dates
The next estimated earnings date is Saturday, August 30, 2025.
| Earnings Date | Aug 30, 2025 |
| Ex-Dividend Date | Jul 16, 2025 |
Share Statistics
| Current Share Class | 6.24B |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.22% |
| Shares Change (QoQ) | +5.39% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 3.38B |
Valuation Ratios
The trailing PE ratio is 14.54 and the forward PE ratio is 13.39.
| PE Ratio | 14.54 |
| Forward PE | 13.39 |
| PS Ratio | 0.86 |
| PB Ratio | 2.11 |
| P/TBV Ratio | 2.45 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 13.61 |
| EV / Sales | 0.80 |
| EV / EBITDA | 8.77 |
| EV / EBIT | 17.15 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.27 |
| Debt / EBITDA | 1.22 |
| Debt / FCF | n/a |
| Interest Coverage | 10.73 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 5.68% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 2.39M |
| Profits Per Employee | 140,979 |
| Employee Count | 84,915 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, SHA:601633 has paid 1.05 billion in taxes.
| Income Tax | 1.05B |
| Effective Tax Rate | 8.10% |
Stock Price Statistics
The stock price has increased by +0.81% in the last 52 weeks. The beta is 0.97, so SHA:601633's price volatility has been similar to the market average.
| Beta (5Y) | 0.97 |
| 52-Week Price Change | +0.81% |
| 50-Day Moving Average | 21.97 |
| 200-Day Moving Average | 24.60 |
| Relative Strength Index (RSI) | 56.12 |
| Average Volume (20 Days) | 18,945,961 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:601633 had revenue of CNY 203.13 billion and earned 11.97 billion in profits. Earnings per share was 1.40.
| Revenue | 203.13B |
| Gross Profit | 37.62B |
| Operating Income | 9.46B |
| Pretax Income | 13.03B |
| Net Income | 11.97B |
| EBITDA | 18.50B |
| EBIT | 9.46B |
| Earnings Per Share (EPS) | 1.40 |
Balance Sheet
The company has 33.82 billion in cash and 22.66 billion in debt, giving a net cash position of 11.16 billion.
| Cash & Cash Equivalents | 33.82B |
| Total Debt | 22.66B |
| Net Cash | 11.16B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 82.66B |
| Book Value Per Share | 9.91 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 18.52%, with operating and profit margins of 4.66% and 5.89%.
| Gross Margin | 18.52% |
| Operating Margin | 4.66% |
| Pretax Margin | 6.41% |
| Profit Margin | 5.89% |
| EBITDA Margin | 9.11% |
| EBIT Margin | 4.66% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.45, which amounts to a dividend yield of 2.01%.
| Dividend Per Share | 0.45 |
| Dividend Yield | 2.01% |
| Dividend Growth (YoY) | 50.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.22% |
| Shareholder Yield | 2.24% |
| Earnings Yield | 6.88% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on October 13, 2015. It was a forward split with a ratio of 3.
| Last Split Date | Oct 13, 2015 |
| Split Type | Forward |
| Split Ratio | 3 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |